214 related articles for article (PubMed ID: 20406987)
1. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.
Qin Z; Dai L; Slomiany MG; Toole BP; Parsons C
Cancer Res; 2010 May; 70(10):3884-9. PubMed ID: 20406987
[TBL] [Abstract][Full Text] [Related]
2. Emmprin and KSHV: new partners in viral cancer pathogenesis.
Dai L; Bai L; Lu Y; Xu Z; Reiss K; Del Valle L; Kaleeba J; Toole BP; Parsons C; Qin Z
Cancer Lett; 2013 Sep; 337(2):161-6. PubMed ID: 23743354
[TBL] [Abstract][Full Text] [Related]
3. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
5. KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction.
Dai L; Bratoeva M; Toole BP; Qin Z; Parsons C
Int J Cancer; 2012 Aug; 131(4):834-43. PubMed ID: 21918972
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q
PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521
[TBL] [Abstract][Full Text] [Related]
8. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus.
Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z
Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574
[TBL] [Abstract][Full Text] [Related]
9. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells.
Dai L; Trillo-Tinoco J; Chen Y; Bonstaff K; Del Valle L; Parsons C; Ochoa AC; Zabaleta J; Toole BP; Qin Z
Oncotarget; 2016 Jan; 7(4):3806-18. PubMed ID: 26675551
[TBL] [Abstract][Full Text] [Related]
10. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
12. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility.
Wu YH; Hu TF; Chen YC; Tsai YN; Tsai YH; Cheng CC; Wang HW
Blood; 2011 Sep; 118(10):2896-905. PubMed ID: 21715310
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.
Lee MS; Jones T; Song DY; Jang JH; Jung JU; Gao SJ
PLoS Pathog; 2014 Sep; 10(9):e1004412. PubMed ID: 25254972
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
16. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.
Sun Z; Xiao B; Jha HC; Lu J; Banerjee S; Robertson ES
J Virol; 2014 Jul; 88(13):7367-78. PubMed ID: 24741095
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
19. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
20. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
